How Do C9ORF72 Repeat Expansions Cause Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Can We Learn from Other Noncoding Repeat Expansion Disorders?

Overview

Journal Curr Opin Neurol

Specialty Neurology

Date 2012 Nov 20

PMID 23160421

Citations 92

Authors

Marka van Blitterswijk

Mariely DeJesus-Hernandez

Rosa Rademakers

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The aim of this review is to describe disease mechanisms by which chromosome 9 open reading frame 72 (C9ORF72) repeat expansions could lead to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) and to discuss these diseases in relation to other noncoding repeat expansion disorders.

Recent Findings: ALS and FTD are complex neurodegenerative disorders with a considerable clinical and pathological overlap, and this overlap is further substantiated by the recent discovery of C9ORF72 repeat expansions. These repeat expansions are currently the most important genetic cause of familial ALS and FTD, accounting for approximately 34.2 and 25.9% of the cases. Clinical phenotypes associated with these repeat expansions are highly variable, and combinations with mutations in other ALS-associated and/or FTD-associated genes may contribute to this pleiotropy. It is challenging, however, to diagnose patients with C9ORF72 expansions, not only because of large repeat sizes, but also due to somatic heterogeneity. Most other noncoding repeat expansion disorders share an RNA gain-of-function disease mechanism, a mechanism that could underlie the development of ALS and/or FTD as well.

Summary: The discovery of C9ORF72 repeat expansions provides novel insights into the pathogenesis of ALS and FTD and highlights the importance of noncoding repeat expansions and RNA toxicity in neurodegenerative diseases.

Citing Articles

Nanostructural Modulation of G-Quadruplex DNA in Neurodegeneration: Orotate Interaction Revealed Through Experimental and Computational Approaches.

Falanga A, Piccialli I, Greco F, DErrico S, Nolli M, Borbone N J Neurochem. 2025; 169(1):e16296.

PMID: 39829311 PMC: 11744338. DOI: 10.1111/jnc.16296.

Why should we care about astrocytes in a motor neuron disease?.

Dittlau K, Van Den Bosch L Front Mol Med. 2024; 3:1047540.

PMID: 39086676 PMC: 11285655. DOI: 10.3389/fmmed.2023.1047540.

Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis.

Jacob S, Lee S, Kim S, Sharkey K, Pfeffer G, Nguyen M Nat Rev Neurol. 2024; 20(8):475-494.

PMID: 38965379 DOI: 10.1038/s41582-024-00991-7.

Understanding the relationship between cerebellum and the frontal-cortex region of C9orf72-related amyotrophic lateral sclerosis: A comparative analysis of genetic features.

Prasad K, Hassan M, Raghuvanshi S, Kumar V PLoS One. 2024; 19(5):e0301267.

PMID: 38753768 PMC: 11098475. DOI: 10.1371/journal.pone.0301267.

Traumatic injury causes selective degeneration and TDP-43 mislocalization in human iPSC-derived -associated ALS/FTD motor neurons.

Martin E, Santacruz C, Mitevska A, Jones I, Krishnan G, Gao F bioRxiv. 2024; .

PMID: 38585915 PMC: 10996466. DOI: 10.1101/2024.03.21.586073.

References

Wheeler T, Lueck J, Swanson M, Dirksen R, Thornton C . Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest. 2007; 117(12):3952-7. PMC: 2075481. DOI: 10.1172/JCI33355. View

DeJesus-Hernandez M, Mackenzie I, Boeve B, Boxer A, Baker M, Rutherford N . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011; 72(2):245-56. PMC: 3202986. DOI: 10.1016/j.neuron.2011.09.011. View

Thornton C, Johnson K, Moxley 3rd R . Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994; 35(1):104-7. DOI: 10.1002/ana.410350116. View

Verbeek D, van de Warrenburg B . Genetics of the dominant ataxias. Semin Neurol. 2012; 31(5):461-9. DOI: 10.1055/s-0031-1299785. View

Khan B, Yokoyama J, Takada L, Sha S, Rutherford N, Fong J . Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry. 2012; 83(4):358-64. PMC: 3388906. DOI: 10.1136/jnnp-2011-301883. View

La Spada A, Taylor J . Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet. 2010; 11(4):247-58. PMC: 4704680. DOI: 10.1038/nrg2748. View

Ferrari R, Mok K, Moreno J, Cosentino S, Goldman J, Pietrini P . Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging. 2012; 33(8):1850.e1-11. PMC: 3743244. DOI: 10.1016/j.neurobiolaging.2012.02.017. View

. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994; 57(4):416-8. PMC: 1072868. DOI: 10.1136/jnnp.57.4.416. View

Radvansky J, Kadasi L . The expanding world of myotonic dystrophies: how can they be detected?. Genet Test Mol Biomarkers. 2010; 14(6):733-41. DOI: 10.1089/gtmb.2010.0073. View

10.

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

11.

Stewart H, Rutherford N, Briemberg H, Krieger C, Cashman N, Fabros M . Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol. 2012; 123(3):409-17. PMC: 3322555. DOI: 10.1007/s00401-011-0937-5. View

12.

van Rheenen W, van Blitterswijk M, Huisman M, Vlam L, van Doormaal P, Seelen M . Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology. 2012; 79(9):878-82. DOI: 10.1212/WNL.0b013e3182661d14. View

13.

Corrado L, Ratti A, Gellera C, Buratti E, Castellotti B, Carlomagno Y . High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat. 2009; 30(4):688-94. DOI: 10.1002/humu.20950. View

14.

Cossee M, Faivre L, Philippe C, Hichri H, De Saint-Martin A, Laugel V . ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystonia. Am J Med Genet A. 2011; 155A(1):98-105. DOI: 10.1002/ajmg.a.33785. View

15.

Chester C, de Carvalho M, Miltenberger G, Pereira S, Dillen L, van der Zee J . Rapidly progressive frontotemporal dementia and bulbar amyotrophic lateral sclerosis in Portuguese patients with C9orf72 mutation. Amyotroph Lateral Scler Frontotemporal Degener. 2012; 14(1):70-2. DOI: 10.3109/17482968.2012.690418. View

16.

Boxer A, Mackenzie I, Boeve B, Baker M, Seeley W, Crook R . Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry. 2010; 82(2):196-203. PMC: 3017222. DOI: 10.1136/jnnp.2009.204081. View

17.

Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

18.

TANEJA K, McCurrach M, Schalling M, Housman D, Singer R . Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol. 1995; 128(6):995-1002. PMC: 2120416. DOI: 10.1083/jcb.128.6.995. View

19.

Jansen G, Willems P, Coerwinkel M, Nillesen W, Smeets H, Vits L . Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet. 1994; 54(4):575-85. PMC: 1918095. View

20.

Lillo P, Hodges J . Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci. 2009; 16(9):1131-5. DOI: 10.1016/j.jocn.2009.03.005. View